BI
Bioextrax AB (publ)
BIOEX.ST · STO
2.30 kr -4.17% (-0.10 kr)
1M -4.17%
Market Cap 114.2M kr
P/E Ratio -
Div. Yield -
ROE 111.12%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
0/9Valuation
17 /100
Expensive P/S 150.92x
P/B 5.39x
P/E N/A
Growth
78 /100
Growing Rev. growth 24.21%
Book val. growth 12.59%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 2,426.42%
Net margin 2,338.84%
Op. margin 2,426.42%
Quality
0 /100
Poor ROIC 86.58%
ROE 111.12%
ROA 71.60%
Debt
64 /100
Moderate Debt/Equity 0.00x
Current ratio 1.58x
Int. coverage -18,368.00x
Stability
39 /100
Moderate Beta 1.49x
Rev. volatility 258.15%
EPS volatility 11.22%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIOEX.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Edvard Hall
Employees
14
Headquarters
Lund
Upcoming events
20 NOV
Earnings
Upcoming earnings report